Thymosin Alpha-1 is a synthetic short-chain research peptide consisting of a defined amino-acid sequence with targeted structural modifications intended to support molecular stability and analytical reliability. Produced using solid-phase peptide synthesis, it is supplied as a white to off-white lyophilized powder consistent with the expected characteristics of high-purity peptides. Thymosin Alpha-1 is commonly utilized in in-vitro research applications, where controlled sequence fidelity, reproducible physicochemical properties, and dependable analytical confirmation are important.
Disclaimer: “Thymosin Alpha-1” is the USAN-designated nonproprietary name for the compound and is not owned or trademarked by any entity. This product is not affiliated with, endorsed by, or intended to reference any branded pharmaceutical product. Thymosin-Alpha-1 is strictly intended for in vitro laboratory research use and is not approved for human or animal use.